Studies on the correlation between rate of biotransformation and haematological toxicity of cyclophosphamide
- PMID: 716950
- DOI: 10.1111/j.1600-0773.1978.tb02274.x
Studies on the correlation between rate of biotransformation and haematological toxicity of cyclophosphamide
Similar articles
-
The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects.Acta Pharmacol Toxicol (Copenh). 1974 Aug;35(2):98-106. doi: 10.1111/j.1600-0773.1974.tb00729.x. Acta Pharmacol Toxicol (Copenh). 1974. PMID: 4479366 No abstract available.
-
"Refractory" thrombocytopenic purpura treated successfully with cyclophosphamide.JAMA. 1971 Jan 18;215(3):445-9. JAMA. 1971. PMID: 5107390 No abstract available.
-
Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone.Ann Intern Med. 1972 Feb;76(2):227-34. doi: 10.7326/0003-4819-76-2-227. Ann Intern Med. 1972. PMID: 5066691 No abstract available.
-
Haematological effects of lithium. A review.Agressologie. 1982 Feb;23(B):105-9. Agressologie. 1982. PMID: 7044164 Review. No abstract available.
-
The comparative pharmacology of cyclophosphamide and ifosfamide.Semin Oncol. 1982 Dec;9(4 Suppl 1):2-7. Semin Oncol. 1982. PMID: 6761865 Review. No abstract available.
Cited by
-
Clinical pharmacokinetics of cyclophosphamide.Clin Pharmacokinet. 2005;44(11):1135-64. doi: 10.2165/00003088-200544110-00003. Clin Pharmacokinet. 2005. PMID: 16231966 Review.
-
Exposure-Toxicity Association of Cyclophosphamide and Its Metabolites in Infants and Young Children with Primary Brain Tumors: Implications for Dosing.Clin Cancer Res. 2020 Apr 1;26(7):1563-1573. doi: 10.1158/1078-0432.CCR-19-2685. Epub 2019 Dec 3. Clin Cancer Res. 2020. PMID: 31796512 Free PMC article. Clinical Trial.
-
Clinical pharmacokinetics of cyclophosphamide.Clin Pharmacokinet. 1979 Sep-Oct;4(5):380-94. doi: 10.2165/00003088-197904050-00004. Clin Pharmacokinet. 1979. PMID: 389529 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources